Page 2 - Nasdaq Bmea News Today

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report)’s share price shot up 2.6% during mid-day trading on Wednesday . The company traded as high as $15.27 and last traded at $15.09. 9,242 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 675,203 shares. The stock had previously closed […]

Biomea Fusion (NASDAQ:BMEA – Get Free Report) and Agile Therapeutics (NASDAQ:AGRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Biomea Fusion has a […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 7,490,000 shares, a decrease of 9.5% from the July 15th total of 8,280,000 shares. Based on an average daily volume of 830,700 shares, […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month target price […]

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]

Monashee Investment Management LLC purchased a new position in Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 90,000 shares of the company’s stock, valued at approximately $2,791,000. Biomea Fusion accounts for about 0.8% […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) traded down 8.4% on Tuesday . The stock traded as low as $20.31 and last traded at $20.38. 184,281 shares traded hands during trading, a decline of 75% from the average session volume of 738,172 shares. The stock had previously closed at $22.25. Wall Street Analysts Forecast […]

Biomea Fusion (NASDAQ:BMEA – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $50.00 price objective on the stock. HC Wainwright’s target price would suggest a potential upside of 172.03% from the company’s current price. […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 8,290,000 shares, an increase of 28.5% from the June 15th total of 6,450,000 shares. Based on an average trading volume of 893,900 shares, the short-interest ratio […]

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 8,290,000 shares, a growth of 28.5% from the June 15th total of 6,450,000 shares. Approximately 28.2% of the company’s stock are short sold. […]